Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRicardo Plc Regulatory News (RCDO)

  • This share is currently suspended. It was suspended at a price of 430.00
  • There is currently no data for RCDO

Director/PDMR Shareholding

16 Oct 2013 16:25

RNS Number : 6917Q
Ricardo PLC
16 October 2013
 



Ricardo PLC

 

Director / PDMR Shareholdings

 

16 October 2013

London

 

1. 2006 Long Term Incentive Plan - grant of plan cycle 7

 

Ricardo PLC (the "Company") announces that, on 16 October 2013, conditional awards over a total of 185,399 shares of 25 pence each in the Company ("Shares") were granted to Executive Directors and other PDMRs under the terms of the Company's 2006 Long Term Incentive Plan (the "LTIP"), as set out below. These awards vest after three years and are subject to TSR and EPS performance conditions.

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

73,380

Ian Gibson

Executive Director

25,983

Mark Garrett

Executive Director

22,676

Martin Fausset

PDMR

14,430

Tom Apostolos

PDMR

9,423

Robert Hentschel

PDMR

8,615

Markus Döerr

PDMR

12,674

Gary Tan

PDMR

9,199

Robert Bell

PDMR

9,019

 

2. 2011 Deferred Bonus Plan - grant of deferred awards and matching awards

 

The Company also announces that, on 16 October 2013, conditional "deferred awards" over a total of 62,931 Shares were granted to Executive Directors and other PDMRs under the terms of the Company's 2011 Deferred Bonus Plan ("DBP"), as set out below. Subject to continuing employment, these awards vest after three years. These DBP deferred awards (which include dividend equivalent entitlements) are not subject to performance conditions.

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

34,292

Mark Garrett

Executive Director

15,620

Martin Fausset

PDMR

5,848

Tom Apostolos

PDMR

3,817

Gary Tan

PDMR

3,354

 

Finally, further conditional "matching awards" over a total of 49,912 Shares were granted to Executive Directors under the terms of the DBP on the basis of one Share comprised in such a "matching award" for each Share comprised in the corresponding deferred award (detailed above) granted to an individual on the same occasion. Details of these DBP matching awards, which do not include dividend equivalent entitlements, but are subject to the same performance conditions that apply to the awards granted on 16 October 2013 under cycle 7 of the LTIP, are set out below:

 

 

 Name

Role

No. of Shares over which awards granted

Dave Shemmans

Executive Director

34,292

Mark Garrett

Executive Director

15,620

 

 

3. Current total holdings of awards / options over Shares

 

Following the above notifications, the total number of Shares over which the relevant Executive Directors and other PDMRs hold outstanding awards / options is set out below:

 

 Name

Role

Total no. of Shares subject to awards and options now held

Approximate % of Company's issued share capital

Dave Shemmans

Executive Director

616,044

1.18%

Ian Gibson

Executive Director

25,983

0.05%

Mark Garrett

Executive Director

221,144

0.42%

Martin Fausset

PDMR

71,753

0.14%

Tom Apostolos

PDMR

36,699

0.07%

Robert Hentschel

PDMR

8,615

0.02%

Markus Döerr

PDMR

99,208

0.19%

Gary Tan

PDMR

29,972

0.06%

Robert Bell

PDMR

23,554

0.05%

 

The above notifications are intended to satisfy the Company's obligations under Disclosure and Transparency Rule ("DTR") 3.1.4R.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZMMMGKVDGFZM
Date   Source Headline
10th Apr 20184:35 pmRNSPrice Monitoring Extension
3rd Apr 20189:04 amRNSHolding(s) in Company
3rd Apr 20187:00 amRNSRicardo completes sale of technical facility
13th Mar 20184:04 pmRNSDirector/PDMR Shareholding
12th Mar 20189:25 amRNSBlock Listing Six Monthly Return
5th Mar 20187:00 amRNSSale of Chicago Technical Faclility
28th Feb 20187:00 amRNSInterim Results
23rd Feb 20183:49 pmRNSNotification of Major Holdings
22nd Feb 20187:00 amRNSNotice of Capital Markets Event
12th Feb 20184:33 pmRNSDirector/PDMR Shareholding
23rd Jan 201810:09 amRNSDirector/PDMR Shareholding
17th Jan 201811:53 amRNSDirector/PDMR Shareholding
17th Jan 20187:00 amRNSTrading Update
3rd Jan 201810:05 amRNSTotal Voting Rights and Captial
15th Dec 201712:06 pmRNSDirector/PDMR Shareholding
7th Dec 20174:22 pmRNSAdditional Listing
7th Dec 20174:21 pmRNSAdditional Listing
29th Nov 20171:43 pmRNSDirector/PDMR Shareholding
15th Nov 201710:58 amRNSDirector/PDMR Shareholding
8th Nov 20173:49 pmRNSResult of AGM
8th Nov 201712:18 pmRNSDirector/PDMR Shareholding
8th Nov 20177:00 amRNSTrading Update
31st Oct 20173:16 pmRNSTotal Voting Rights
31st Oct 201710:02 amRNSDirector/PDMR Shareholding
26th Oct 20178:39 amRNSDirector/PDMR Shareholding
25th Oct 20177:00 amRNSAppointment of Joint Corporate Broker
12th Oct 20174:39 pmRNSDirector/PDMR Shareholding
3rd Oct 201712:45 pmRNSDirector/PDMR Shareholding
21st Sep 20179:50 amRNSHolding(s) in Company
14th Sep 20177:00 amRNSFull Year Results
13th Sep 201711:53 amRNSDirector/PDMR Shareholding
12th Sep 20172:02 pmRNSBLOCK LISTING ANNOUNCEMENT
17th Aug 201712:55 pmRNSHolding(s) in Company
14th Aug 201711:12 amRNSDirector/PDMR Shareholding
8th Aug 20179:46 amRNSHolding(s) in Company
2nd Aug 20177:00 amRNSAcquisition
25th Jul 20173:43 pmRNSHolding(s) in Company
12th Jul 20172:25 pmRNSDirector/PDMR Shareholding
6th Jul 20177:00 amRNSTrading Update & Notice of Capital Markets Event
21st Jun 201711:52 amRNSHolding(s) in Company
12th Jun 20173:18 pmRNSDirector/PDMR Shareholding
12th May 20178:44 amRNSDirector/PDMR Shareholding
11th May 20179:27 amRNSHolding(s) in Company
9th May 20172:23 pmRNSDirector/PDMR Shareholding
24th Apr 20171:58 pmRNSDirectorate Change
12th Apr 20179:53 amRNSDirector/PDMR Shareholding
12th Apr 20179:50 amRNSDirector/PDMR Shareholding
11th Apr 20178:58 amRNSHolding(s) in Company
10th Apr 20173:44 pmRNSHolding(s) in Company
13th Mar 201712:06 pmRNSBlock listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.